These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Mineralocorticoids, hypertension, and cardiac fibrosis. Young M; Fullerton M; Dilley R; Funder J J Clin Invest; 1994 Jun; 93(6):2578-83. PubMed ID: 8200995 [TBL] [Abstract][Full Text] [Related]
6. Induction of cardiac fibrosis by aldosterone. Lijnen P; Petrov V J Mol Cell Cardiol; 2000 Jun; 32(6):865-79. PubMed ID: 10888242 [TBL] [Abstract][Full Text] [Related]
7. [Profibrotic effects of aldosterone]. Van Den Meiracker AH; Huizenga AT; Boomsma F Ned Tijdschr Geneeskd; 2004 Jul; 148(31):1532-6. PubMed ID: 15366722 [TBL] [Abstract][Full Text] [Related]
8. Evidence for myocardial synthesis of aldosterone producing myocardial fibrosis in man. Struthers AD Clin Sci (Lond); 2002 Apr; 102(4):387. PubMed ID: 11914099 [No Abstract] [Full Text] [Related]
9. Cyclosporine induced myocardial fibrosis: a unique controlled case report. Karch SB; Billingham ME J Heart Transplant; 1985 Feb; 4(2):210-2. PubMed ID: 3916487 [TBL] [Abstract][Full Text] [Related]
10. [Myocardial fibrosis--the theoretical bases, clinical aspects and therapeutic implications]. Perdigão C Rev Port Cardiol; 1993; 12(7-8):675-85, 603. PubMed ID: 8352988 [TBL] [Abstract][Full Text] [Related]
11. A neuroendocrine-immune interface. The immunostimulatory state of aldosteronism. Weber KT Herz; 2003 Dec; 28(8):692-701. PubMed ID: 14689103 [TBL] [Abstract][Full Text] [Related]
12. A primer on aldosterone for gynecologists/obstetricians. Pitt B J Reprod Med; 2007 Feb; 52(2 Suppl):153-8. PubMed ID: 17477109 [TBL] [Abstract][Full Text] [Related]
13. [Non-genomic aldosterone action. A new concept for the mechanism of action of steroids is developed]. Wehling M; Scriba PC Internist (Berl); 1995 Apr; 36(4):338-42. PubMed ID: 7775081 [No Abstract] [Full Text] [Related]
14. Endomyocardial fibrosis, a case for the tropical doctor. Kartha CC Cardiovasc Res; 1995 Nov; 30(5):636-43. PubMed ID: 8595606 [No Abstract] [Full Text] [Related]
15. Comparison of isoproterenol and dobutamine in the induction of cardiac hypertrophy and fibrosis. Anderson M; Moore D; Larson D Perfusion; 2008 Jul; 23(4):231-5. PubMed ID: 19181756 [TBL] [Abstract][Full Text] [Related]
16. Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart. Satoh M; Nakamura M; Saitoh H; Satoh H; Akatsu T; Iwasaka J; Masuda T; Hiramori K Clin Sci (Lond); 2002 Apr; 102(4):381-6. PubMed ID: 11914098 [TBL] [Abstract][Full Text] [Related]
17. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?]. Brilla CG; Schencking M; Scheer C; Rupp H Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851 [TBL] [Abstract][Full Text] [Related]
18. Cardiac remodelling by fibrous tissue: role of local factors and circulating hormones. Sun Y; Weber KT Ann Med; 1998 Aug; 30 Suppl 1():3-8. PubMed ID: 9800877 [TBL] [Abstract][Full Text] [Related]
20. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure. Dieterich HA; Wendt C; Saborowski F Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]